Induction and spreading of tou pathology in a mouse model of Alzheimer's disease;Induction et propagation de la pathologie par la protéine tau chez un modèle murin de la maladie d'Alzheimer

Medecine/Sciences

Volumn 26, Issue 2, 2010, Pages 121-124

  Clavaguera, Florence ^a   Goedert, Michel ^b   Tolnay, Markus ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77749319550     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2010262121     Document Type: Article

References (22)

1. Goedert M, Spillantini MG. A century of Alzheimer's disease. Science 2006;314:777-81.
2. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59.
3. Götz J, Chen F, van Dorpe J, Nitsch RM. Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Abeta 42 fibrils. Science 2001;293:1491-5.
4. Bolmont T, Clavaguera F, Meyer-Luehmann M, et al. Induction of tau pathology by intracerebral infusion of amyloid-β-containing brain extract and by amyloid-β deposition in APP X tau transgenic mice. Am J Pathol 2007; 171:2012-20.
5. Poorkaj P, Bird TD, Wijsman E, et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998;43:815-25.
6. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702-5.
7. Spillantini MG, Murrell JR, Goedert M, et al. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998;95:7737-41.
8. S. Frank S, Clavaguera F, Tolnay M. Tauopathy models and human neuropathology: similarities and differences. Acta Neuropathol 2008;115:39-53.
9. Allen B, Ingram E, Takao M, et al. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J Neurosci 2002;22:9340-51.
10. Probst A, Götz J, Wiederhold KH, et al. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol 2000;99:469-81.
11. Prusiner, S. B. Prions. Proc Natl Acad Sci USA 1998;95:13363-83.
12. Kane MD, Lipinski WJ, Callahan MJ, et al. Evidence for seeding of β-amyloid by intracerebral infusion of Alzheimer brain extracts in βamyloid precursor protein-transgenic mice. J Neurosci 2000;15:3606-11.
13. Meyer-Luehmann M, Coomaraswamy J, Bolmont T, et al. Exogenous induction of cerebral beta-amyloidosis is governed by agent and host. Science 2006;313:1781-4.
14. Li JY, Englund E, Holton JL, et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 2008;14:501-3.
15. KordowerJH, Chu Y, Hauser RA, Freeman TB, Olanow CW. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 2008;14:504-6.
16. Desplats P, Lee HJ, Bae EJ, et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein. Proc Natl Acad Sci USA 2009;106:13010-5.
17. Ren PH, Lauckner JE, Kachirskaia I, et al. Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat Cell Biol 2009;11:219-25.
18. Frost B, Jacks RL, Diamond Ml. Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 2009;284:12845-52.
19. Eisele YS, Bolmont T, Keikenwalder M, et al. Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation. Proc Natl Acad Sci USA 2009;106:12926-31.
20. Langui D, Lachapelle F, Duyckaerts C. Animal models of neurodegenerative diseases. Med Sci (Paris) 2007;23:180-6.
21. Lelan F, Damier P. Grafted dopaminergic neurons are targeted by the disease process in Parkinson's disease. Med Sci (Paris) 2009;25:15-6.
22. Götz J, Probst A, Spillantini MG, et al. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. EMBO J 1995;14:1304-13.